No change in plasma tau and serum neurofilament light concentrations in adolescent athletes following sport-related concussion by Wallace, C et al.
RESEARCH ARTICLE
No change in plasma tau and serum
neurofilament light concentrations in
adolescent athletes following sport-related
concussion
Colin WallaceID1,2☯*, Henrik Zetterberg3,4,5,6☯, Kaj Blennow3,4‡, Paul van Donkelaar1‡
1 School of Health and Exercise Sciences, University of British Columbia, Kelowna, British Columbia,
Canada, 2 Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver,
British Columbia, Canada, 3 Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mo¨lndal,
Sweden, 4 Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology,
Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Mo¨lndal, Sweden,
5 Department of Molecular Neuroscience, UCL Institute of Neurology, London, United Kingdom, 6 UK
Dementia Research Institute at UCL, London, United Kingdom
☯ These authors contributed equally to this work.
‡ These authors also contributed equally to this work.
* colin.wallace@alumni.ubc.ca
Abstract
Sport-related concussion (SRC), a mild form of traumatic brain injury (TBI), is a common
injury in contact sports. Health care professionals rely on subjective criteria (e.g., symp-
toms), as there is no objective marker for identification of athletes with SRC. Blood-based
biomarkers have shown promise as diagnostic and prognostic tools following TBI and SRC.
In the present study, we examined plasma tau and serum NF-L, two biomarkers for neuro-
nal/axonal injury, concentrations at preseason and following SRC in contact sport athletes
(n = 11) using ultrasensitive single molecule array (Simoa) assays. Preseason baseline
samples were collected, and post-concussion samples were obtained at 6- and 14-days
following injury. We found no difference between baseline, 6-day and 14-day post-concus-
sion concentrations of tau (p = 0.14) or NF-L (p = 0.53). Further, no difference was found
between preseason baseline and all post-SRC samples for tau (p = 0.22) or NF-L (p = 0.98).
The total number of symptoms reported on the Standardized Assessment of Concussion–
3rd Edition (SCAT3) and associated symptom severity scores increased from preseason
to 6-days post-SRC but returned to baseline values at 14-days (p = 0.02 and p = 0.003,
respectively). These results suggest that the severity of neuronal injury in this cohort of con-
tact sport athletes with clinical uncomplicated SRC was too low to be detected by tau and
NF-L measurements in blood samples obtained at 6- and 14-days post-injury.
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Introduction
Traumatic brain injury (TBI) is a growing public health concern: upwards of 3.8 million TBIs,
including sport-related concussions (SRC), occur each year in the United States alone.[1] The
incidence of SRC is much higher in contact sport athletes (e.g., American football, rugby, ice
hockey, etc.) than in non-contact sport athletes (e.g., track and field).[2–5] SRC symptoms are
highly variable and largely subjective, and affect somatic, cognitive, and emotional systems fol-
lowing injury.[6] Therefore, SRC is challenging to detect and diagnose, as there remains no
objective diagnostic tool for either the acute or chronic stage.[7] SRC diagnosis is based on
clinical criteria, including athlete-reported symptoms, cognitive function screening, and bal-
ance testing.[6] Improvements in symptom severity, balance deficits, and cognitive dysfunc-
tion guide return-to-play (RTP) progression with the majority of athletes who suffer a SRC
being cleared to RTP within 2 weeks of injury.[6] However, executive dysfunction is shown to
persist no less than 2 months post-injury,[8] suggesting clinical recovery and RTP occurs prior
to full functional recovery. An objective diagnostic test in the acute phase following SRC used
in conjunction with clinical symptom resolution would better ensure athletes RTP at the
appropriate time.
Many sports require rapid decision making through complex mental operations. As such,
separation of clinical and physiological recovery may result in a greater risk of injury due to
cognitive impairments. Indeed, SRC increases the risk of lower body orthopaedic injury in col-
legiate athletes up to 1-year post-concussion compared to before the SRC occurred, and when
compared to a group of nonconcussed athletes.[9] Reaction time is also increased following
SRC in tasks engaging executive function networks,[8,10] offering a possible explanation for
increased rates of lower body orthopaedic injury. Taken together, this suggests that functional
deficits reflect an underlying pathology that cannot be accurately defined by current subjective
criteria.
In addition to the short-term effects of a concussive injury, repetitive concussive and sub-
concussive impacts sustained over many years are proposed mechanisms for the development
of certain neurodegenerative conditions, specifically chronic traumatic encephalopathy (CTE).
[11] CTE is a progressive neurodegenerative condition with clinical symptoms typically pre-
senting several years after removal from head impact exposure,[12] and diagnosis is possible
only at post-mortem evaluation.[11] Recently, an in vivo neural imaging method of detecting
CTE through the presence of unique positron emission tomography (PET) [F18]FDDNP
binding patterns was proposed through a case study involving 1 retired National Football Lea-
gue player;[13] however, more research is required to establish the clinical application of this
modality. No in vivo objective markers are currently available to quantify the extent of neuro-
nal or glial damage in the brain due to head trauma, nor are there tools for determining physi-
ological recovery from these impacts.[7]
Fluid-based biomarkers have been investigated as potential indicators of SRC, with both
tau and neurofilament light (NF-L) hypothesized to be optimal markers of axonal damage.[7]
Tau is a CNS-enriched microtubule-associated protein predominantly expressed in thin,
unmyelinated axons and is involved in the formation and stability of microtubules.[14] Levels
of total tau in cerebrospinal fluid (CSF) increase dramatically following acute TBI, with the
degree of increase predicting long-term clinical outcome.[15] Plasma levels of total tau (T-tau)
have been shown to be elevated up to 144-hours following concussion in professional ice
hockey players compared to preseason baseline samples in uninjured controls, with the highest
concentration measured 1-hour post-injury.[16] Similarly, Neselius et al. (2013) showed
increased plasma T-tau in amateur boxers after a bout compared to controls.[17] Interestingly,
Gill et al. (2017) found lower levels of plasma tau in concussed athletes at 24 and 72 hours
Tau and neurofilament light following sport-related concussion
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post-injury when compared to nonconcussed athletes sampled at similar time points, although
both concussed and nonconcussed athletes had higher levels of plasma tau compared to
healthy controls with no history of head trauma.[18] This suggests a possible effect of exercise
on circulating plasma tau concentration. Indeed, Shahim et al. (2018) found elevated levels of
plasma tau 1-hour following exercise; however, concentration returned to baseline levels at
12-hours following exertion. [19] This should be considered when examining samples from
early time points in acute concussed athletes.
NF-L is a CNS-enriched protein highly expressed in myelinated, long-caliber subcortical
axons and contributes to the strength of the axon.[7] Following concussion, serum NF-L is
increased in professional ice hockey players compared to uninjured controls and follows an
upward trajectory with the highest concentrations seen at 12- and 144-hours post-injury.[20]
After severe TBI, serum NF-L concentration peaks at 10–12 days.[21] Serum NF-L is also
increased at 7–10 days in amateur boxers with no clinically diagnosed concussion following a
match[20] and at the conclusion of an American football season compared to preseason val-
ues,[22] suggesting that repetitive, subconcussive impacts also cause damage to axonal struc-
tures. Unlike plasma tau, serum NF-L concentration is not affected by physical exertion. [19]
An objective method of concussion detection must be developed that is sensitive, measure-
able, reliable, repeatable, quick, and cost-effective.[7] A significant, sustained increase in the
biomarker is required to truly distinguish between concussed and nonconcussed individuals.
In the present study, we examined the dynamics of tau and NF-L in response to SRC in a
cohort of junior and collegiate-aged American football and hockey athletes with the expressed
interest in extending the temporal profile of these proteins post-concussion. Increased concen-
trations of these proteins 2 weeks post-concussion may reflect continuous release from the
brain parenchyma, indicating prolonged axonal breakdown.
Methods
Study population and blood sample processing
This prospective cohort study enrolled 142 male American football (n = 94) and ice hockey
(n = 48) players in Kelowna, British Columbia, Canada. Blood samples were collected by stan-
dard venipuncture through a vein in the antecubital fossa into one K2EDTA tube for plasma
and one serum separator tube. Plasma samples were kept on ice until centrifugation, which
occurred within 60 minutes of collection. Serum samples collected in the laboratory at the Uni-
versity of British Columbia were kept at room temperature for 30 minutes to allow for coagula-
tion. Serum samples collected on site at the athletic training facility for each team were
transported to the University of British Columbia on ice, removed, and kept at room tempera-
ture for 60 minutes to allow for coagulation. All samples were centrifuged at 1200g for 15 min-
utes, aliquoted, and stored at -80˚C until the end of the study period. Once the study had
ended, all samples were shipped on dry ice to Sahlgrenska University Hospital at the Univer-
sity of Gothenburg, Sweden for analysis. This study was approved by the Clinical Research
Ethics Board at the University of British Columbia, Canada and was conducted in accordance
to principles expressed in the Declaration of Helsinki. Written informed consent was obtained
from all participants aged 18 or over, and written informed assent was obtained from the
guardians of athletes under the age of 18.
Blood sampling and quantification procedures
We collected preseason blood samples from all 142 male contact sport athletes. 13 (mean age
18.5 years ± 1.7) were subsequently diagnosed with a concussion, which was confirmed by
team medical personnel using the Standardized Concussion Assessment Tool– 3rd Edition
Tau and neurofilament light following sport-related concussion
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(SCAT3) and consented to serial blood draws at 6- and 14-days post-injury. Athletes did not
report a secondary injury at the time of concussion, and no loss of consciousness (LOC) was
reported. All athletes returned to play within 3 weeks of injury. Eight players had previously
suffered a concussion during their athletic career with an average of 1.1 ± 1.1 concussions for
the group. We chose the 6- and 14-day time points to extend the temporal profile of these pro-
teins and build on their previously reported kinetics.[16,20]
Quantification of plasma tau and serum NF-L occurred on the single molecule array
(Simoa) HD-1 analyzer (Quanterix, Lexington, MA, USA), as previously described.[16,23] The
Simoa HD-1 analyzer platform isolates individual capture beads in arrays of femtoliter-sized
reaction wells, resulting in assay sensitivity 1000x greater than conventional enzyme linked
immunosorbent assay (ELISA) techniques.[24,25] Lower limit of quantification (LLOQ) val-
ues 1.22 pg/mL and 0.58 pg/mL for tau and NF-L, respectively, using standard 4-fold sample
dilutions. Samples were run in duplicate over two lots with samples from the same athlete run
on the same plate by board-certified technicians blinded to clinical information. The coeffi-
cients of variation for all samples reported were< 20%.
Statistical analysis methods
Statistical analyses were conducted with Statistical Package for the Social Sciences (SPSS) ver-
sion 23 (IBM Corporation, Armonk, NY) and figures were developed using GraphPad Prism
version 7.0 (GraphPad Software, San Diego, CA). We compared tau and NF-L concentrations
across 3 time points (preseason, 6-days post-concussion, 14-days post-concussion) using sepa-
rate repeated measures analyses of variance (rmANOVA) for each protein. A Mann-Whitney
U test was run to determine if there were differences in tau concentration from preseason to
post-concussion as the data were not normally distributed. Due to the normality of the NF-L
data, an independent-samples t-test was run to determine if there were differences in concen-
tration from preseason to post-concussion. A Friedman test was run to determine if there
were differences in the total number of symptoms reported on the SCAT3 and symptom sever-
ity score as the data were not normally distributed. Pairwise comparisons were performed
with a Bonferroni correction for multiple comparisons. A rmANOVA was used to determine
whether there were statistically significant differences in the total number of errors reported
on the Balance Error Scoring System (BESS) and Standardized Assessment of Concussion
score.
Results
Participants and blood samples
Table 1 provides biomarker information on the subjects in this study. Two participants were
unable to provide 6-day follow-up blood samples due to travel, and so protein concentrations
were removed from repeated measures analyses. Although there were no significant changes
in biomarker concentrations following concussion, mean tau concentration for the remaining
11 athletes was 2.56 ± 1.02, 2.96 ± 1.46 pg/mL and 3.48 ± 2.34 pg/mL at baseline, 6-days post-
injury and 14-days post-injury (Fig 1A), respectively. Mean NF-L concentration was 8.47 ±
2.77 pg/mL at baseline, 9.05 ± 3.42 pg/mL and 8.45 ± 3.48 pg/mL at 6- and 14-days (Fig 1B),
respectively. rmANOVA analysis revealed no significant differences across time for both tau
(F(2, 20) = 2.184, p = 0.14) and NF-L (F(2, 20) = 0.654, p = 0.53) (Fig 2A and 2B).
Median tau preseason (2.48 pg/mL) and all post-concussion (3.08 pg/mL) concentrations
were not statistically significantly different, U = 195, z = 1.241, p = 0.22 (Fig 2A). There was no
difference between preseason (mean ± SD, 8.17 ± 2.93 pg/mL) and all post-concussion
(mean ± SD, 8.20 ± 3.74 pg/mL) NF-L concentrations, t(35) = -0.024, p = 0.98 (Fig 2B).
Tau and neurofilament light following sport-related concussion
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SCAT3 results
Sport-related concussion elicited a statistically significant difference in the total number of
symptoms reported, χ2(2) = 7.895, p = 0.02, and symptom severity score, χ2(2) = 11.385,
p< 0.01 (Fig 3A and 3B). Post-hoc analysis revealed a statistically significant increase in the
total number of symptoms reported from preseason (Mdn = 1) to 6-days post-concussion
(Mdn = 16) (p = 0.05), and a return to baseline levels at 14-days following injury (Mdn = 0;
p = 0.05). Post-hoc analysis revealed a statistically significant increase in symptom severity
score from preseason (Mdn = 1) to 6-days post-concussion (Mdn = 16) (p = 0.02). Symptom
severity score values returned to baseline levels at 14-days post-concussion (Mdn = 0;
p = 0.01). There was no statistically significant difference between total number of errors on
the BESS (p = 0.18) and SAC total (p = 0.31) (Figs 4 and 5).
Discussion
To our knowledge, our study is the first to examine baseline and post-SRC samples from the
same individuals. All documented SRC included in the present study were considered uncom-
plicated, as all athletes began a graduated RTP protocol within 10-days of injury upon resolu-
tion of symptoms and returned to play within 17-days following injury. Uncomplicated SRC
Table 1. Biomarker concentrations and SCAT3 metrics before and after sport-related concussion.
Characteristic Time p-value
Preseason 6 Days 14 Days
Tau (pg/mL) 2.56 ± 1.02 2.96 ± 1.46 3.48 ± 2.34 0.14
NF-L (pg/mL) 8.47 ± 2.77 9.05 ± 3.42 8.45 ± 3.48 0.53
Number of symptoms reported 1 (0–2) 16 (3–19) 0 (0–2) 0.02
Symptom severity 1 (0–5) 16 (6–60) 0 (0–4) 0.003
BESS total errors 3.71 ± 2.29 4.71 ± 3.30 2.43 ± 2.64 0.18
SAC total 26.71 ± 1.89 25.00 ± 2.08 25.86 ± 2.61 0.31
BESS, balance error scoring system; NF-L, neurofilament light; SAC, standardized assessment of concussion; SRC, sport-related concussion
All data are presented as mean ± standard deviation, except SCAT3 number of symptoms and symptom severity, which are presented as median (range).
https://doi.org/10.1371/journal.pone.0206466.t001
Fig 1. Tau and NF-L concentrations do not change following uncomplicated SRC. (A) Tau concentrations at baseline, and at 6- and 14-days following
uncomplicated SRC. (B) NF-L concentrations at baseline, and at 6- and 14-days following uncomplicated SRC.
https://doi.org/10.1371/journal.pone.0206466.g001
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resulted in no significant increase in plasma tau and serum NF-L at 6- and 14-days post-con-
cussion relative to their baseline concentrations (Fig 1). Further, no significant differences
were found between preseason and all post-concussion concentrations for tau (Fig 2A) or
NF-L (Fig 2B).
Sport-related concussion is caused by an external force to the body transmitted to the head,
[6] after which a variety of cognitive (e.g., feeling like in a fog), somatic (e.g., headache) and
emotional (e.g., rapid changes in mood) symptoms arise. The degree of increase in plasma tau
concentration at 1-hour following SRC is correlated with the length of time to symptom reso-
lution[16] and the degree of symptom severity.[19] Further, Shahim et al. (2014) found ele-
vated plasma tau in concussed professional hockey players with post-concussion symptoms
Fig 2. Tau and NF-L concentrations at preseason and following uncomplicated SRC (all time points). (A) Tau concentrations were unchanged in post-
concussion samples (all times) compared to preseason samples. (B) There was no difference between preseason and post-concussion (all times) NF-L
concentrations.
https://doi.org/10.1371/journal.pone.0206466.g002
Fig 3. Total number of symptoms and symptom severity scores assessed by SCAT3 at preseason and following uncomplicated SRC. (A) The total number
of symptoms reported on the SCAT3 increased from preseason to 6-days following uncomplicated SRC and returned to baseline at 14-days. Maximum possible
number of symptoms is 22. (B) Symptom severity scores increased at 6-days following uncomplicated SRC compared to baseline and returned to baseline at
14-days following injury. Maximum possible symptom severity score is 132.
https://doi.org/10.1371/journal.pone.0206466.g003
Tau and neurofilament light following sport-related concussion
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(PCS) lasting longer than 6-days compared to concussed players with PCS lasting less than
6-days,[16] and Gill et al. (2017) found elevated plasma tau in concussed athletes experiencing
longer RTP timelines than concussed athletes with a relatively short RTP.[18] Serum NF-L is
elevated in athletes with PCS lasting longer than 6-days; however, serum NF-L concentration
mirrors that of uninjured controls in athletes who report full resolution of symptoms within
6-days of SRC.[20] Therefore, a detectable increase in both proteins may reflect more wide-
spread axonal trauma. As such, it has been hypothesized that quantitation of these biomarkers
in blood can be used as an objective clinical tool to detect complicated SRC (i.e., SRC with
Fig 4. Total number of errors on the balance error scoring system (BESS) at preseason, and 6- and 14-days
following uncomplicated SRC. The total number of errors assessed by the BESS was unchanged following
uncomplicated SRC compared to preseason values. The BESS is calculated by adding one point per error during 3
separate 20-second tests.
https://doi.org/10.1371/journal.pone.0206466.g004
Fig 5. Total number of correct answers on the standardized assessment of concussion (SAC) at preseason, and 6-
and 14-days following uncomplicated SRC. Total number of correct answers, out of 31, was unchanged following
uncomplicated SRC compared to preseason values.
https://doi.org/10.1371/journal.pone.0206466.g005
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symptoms lasting longer than 6-days). The data in the present study suggest that plasma tau
and serum NF-L may not be sensitive enough to detect uncomplicated SRC at 6- and 14-days
post-injury in adolescent athletes that experience a rapid RTP; this could be attributed to a
lower severity of axonal damage than in previous studies.[16–18]
One athlete in the present study experienced an elevation in both plasma tau and serum
NF-L at 6-days compared to baseline, and again at 14-days compared to 6-days. At 6-days
post-concussion this subject reported 19 total symptoms on the SCAT3 with a symptom sever-
ity score of 60. This was increased compared to median group values of number of symptoms
(i.e., 10) and symptom severity (i.e., 16), indicating the possibility of a more serious injury;
however, this athlete had a full RTP in 12 days, reported no symptoms at 14-days post-injury,
and BESS errors (i.e., 7) and SAC total (i.e., 25) at 14-days post-injury mirrored his preseason
values. No significant differences were seen between this player and the remaining 10 athletes
concerning age and concussion history (i.e., 1 prior concussion).
Cognitive and balance assessments on the SCAT3 were performed immediately before each
blood draw. The SAC is a clinically validated tool for the assessment of SRC;[26] however,
players reevaluated with the SAC at 48 hours post-injury and beyond have reported similar
scores to baseline values.[27,28] Athletes in the present study completed the SAC well outside
this time point following injury and no differences in score were found, highlighting the
importance of evaluating athletes for SRC as close to the time of injury as possible. The BESS
has not shown consistent reliability across the literature[29] and a learning effect has been
reported in athletes.[30] Healthcare practitioners should be cautious when performing this
assessment post-SRC, especially if administered on several occasions, as practice effects could
mask any abnormalities that may be present.
Tau and NF-L are key structural components of grey-matter and white-matter axons,
respectively, and their quantification in blood following a suspected SRC may help health care
professionals accurately identify and grade neuronal injury in a concussed athlete. Indeed, sev-
eral researchers have shown increases in both plasma tau and serum NF-L following SRC com-
pared to baseline control.[16–18,20] With respect to tau, these increases are more pronounced
in the initial hours following injury,[16,18] whereas NF-L appears to have a slower release into
circulating blood.[20] Further, serum NF-L levels correlate with both cerebrospinal fluid
(CSF) levels following severe TBI,[21] and magnetic resonance diffusion tensor imaging
abnormalities 12 months following diffuse axonal injury (DAI).[31] Similar trends have been
found for other analytes, including glial fibrillary acidic protein,[32] enzyme-cleaved frag-
ments of tau,[33] and calpain-derived αII-spectrin.[34] As no fluid-based biomarker test for
SRC has been approved for clinical use, diagnosis remains focused on cognitive function, bal-
ance testing, and symptoms. If a SRC is suspected, and an athlete reports any symptom associ-
ated with a SRC, the athlete should be removed from play immediately; however, athletes may
not report symptoms immediately following injury[35], and so it is imperative that research in
this area continues so as to identify blood-based biomarkers that can detect SRC across the
entire spectrum of severity.
In conclusion, our study suggests that uncomplicated SRC is not associated with increases
in plasma tau or serum NF-L concentrations at 6- and 14-days following injury. The diagnosis
of SRC is difficult, as it is primarily based on athlete-reported symptoms and these can vary
greatly in time to onset, duration and severity, making SRC a truly complex injury.[36] Cur-
rently, there is no gold standard for immediate detection of SRC. With retired National Foot-
ball League players reporting as many as 12 concussions in their career,[37] and as many as
50% of all National Collegiate Athletic Association (NCAA) athletes report having suffered at
least 1 concussion during their university years,[38] an objective marker that could be used to
identify the injury, track athlete recovery, and inform on RTP timelines would be highly
Tau and neurofilament light following sport-related concussion
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welcomed by the medical community. More research is needed to identify an objective marker
directly related to the pathophysiological processes that occur in the brain post-injury.
This study certainly has limitations. The sample size of the current study was small. Further,
all reported SRC were mild in nature, as all athletes experienced full RTP within 3 weeks. As
plasma tau and serum NF-L are elevated following SRC in individuals with PCS lasting greater
than 6-days, an increase in concentration may reflect a more serious injury. No neuroimaging
or biomechanical data collection took place. The 6- and 14-day time points were chosen to
extend the temporal profile; however, these time points may be outside the time period to
observe significant changes.[39,40]
Despite the limitations, the data presented are novel in that this is the first study to examine
plasma tau and serum NF-L in the same cohort of athletes from preseason to post-concussion.
Plasma tau and serum NF-L appears to remain unchanged in uncomplicated SRC but will
increase in concentration in complicated SRC with persistent symptoms. More research is
needed in order to identify blood-based biomarkers that can detect SRC across the entire spec-
trum of severity.
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